MedTrace Logo

Electrical Cardioversion of Recent Onset Atrial Fibrillation - Silent Thromboembolic Events, Reverse Atrial Remodeling

NCT02955004 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2019-09-17

No results posted yet for this study

Summary

The purpose of this study is to study the effects of transthoracic electrical cardioversion for restoration of sinus rhythm in patients who present with recent onset atrial fibrillation, with regard to new silent cerebral thrombo-embolic lesions and cognitive function, as well as electrical and functional/structural reverse remodelling, and its effects on inflammatory changes / specific cardiac biomarkers, vasoactive peptides, coagulation activity, and active fibrinolysis.

Conditions

  • Intracranial Embolism

Interventions

PROCEDURE

Electrical cardioversion

Transthoracic direct current electrical cardioversion

Sponsors & Collaborators

  • Swedish Heart Lung Foundation

    collaborator OTHER

  • Advanz Pharma

    collaborator INDUSTRY

  • Uppsala University Hospital

    lead OTHER

Principal Investigators

  • Carina M Blomstrom Lundqvist, MD, PhD · Department of Cardiology, Institution of Medical Science

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2017-11-30
Completion
2017-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02955004 on ClinicalTrials.gov